Table Of Contents Global Topical Cortiocosteroids Market
1. Introduction

1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Topical Corticosteroids Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered

2. Market Segmentation

2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

3. Market Overview

3.1. Drivers

3.1.1. Increasing Prevalence Of Chronic Disease Or Condition
3.1.2. Growing Number Of Geriatric Population
3.1.3. Growth In Demand Of Topical Drug Delivery Drugs
3.1.4. Increasing Investment In Research And Development
3.1.5. New Product Launches By Key Players

3.2. Restraints

3.2.1. Expiry Of Patent For Drugs
3.2.2. Weak Reimbursement Policies
3.2.3. Stringent Regulatory Policies

3.3. Opportunities

3.3.1. High Investments In R&D To Innovate New Products
3.3.2. Lucrative Opportunities In Emerging Market
3.3.3. Increasing Mergers And Acquisitions

3.4. Challenges

3.4.1. Pricing Pressure By Government
3.4.2. Side Effects Of Topical Corticosteroids

4. Executive Summary

5. Premium Insights

6. Global Topical Corticosteroids Market, By Molecule Name

6.1. Overview
6.2. Fludroxycortide
6.3. Triamcinolone Acetonide
6.4. Fluocinolone Acetonide
6.5. Antiseptics
6.6. Betamethasone
6.7. Clobetasone Propionate
6.8. Clobetasone Butyrate
6.9. Halobetasone
6.10. Mometasone
6.11. Others

7. Global Topical Corticosteroids Market, By Potency Class

7.1. Overview

7.2. Ultra High

7.2.1. Clobetasol Propionate
7.2.2. Diflorasone Diacetate
7.2.3. Betamethasone Dipropionate Glycol

7.3. High

7.3.1. Amcinonide
7.3.2. Betamethasone Dipropionate
7.3.3. Desoximetasone
7.3.4. Fluocinonide
7.3.5. Others

7.4. Moderate

7.4.1. Desoximetasone
7.4.2. Fluocinolone Acetonide
7.4.3. Fludroxycortide
7.4.4. Hydrocortisone Valerate
7.4.5. Triamcinolone Acetonide
7.4.6. Clobetasone Butyrate
7.4.7. Others

7.5. Mild

7.5.1. Hydrocortisone
7.5.2. Hydrocortisone Acetate
7.5.3. Betamethasone Valerate
7.5.4. Desonide
7.5.5. Fluocinolone Acetonide
7.5.6. Others

8. Global Topical Corticosteroids Market, By Application

8.1. Overview
8.2. Acne
8.3. Dermatitis
8.4. Psoriasis
8.5. Skin Infection
8.6. Hyperpigmentation
8.7. Melasma
8.8. Others

9. Global Topical Corticosteroids Market, By Medication Type

9.1. Overview
9.2. Ointments
9.3. Creams
9.4. Liquid & Solutions
9.5. Lotions
9.6. Gel
9.7. Oils
9.8. Pastes
9.9. Sprays
9.10. Others

10. Global Topical Corticosteroids Market, By End-User

10.1. Overview
10.2. Hospital
10.3. Dermatology Clinics
10.4. Homecare
10.5. Others

11. Global Topical Corticosteroids Market, By Distribution Channel

11.1. Overview
11.2. Hospital Pharmacies
11.3. Pharmacy Stores
11.4. Online Pharmacies
11.5. Others

12. Global Topical Corticosteroids Market, By Purchase Mode

12.1. Overview
12.2. Over The Counter (Otc) Based
12.3. Prescription Based

13. Global Topical Corticosteroids Market, By Brands

13.1. Overview
13.2. Betnovate
13.3. Betnovate N
13.4. Panderm Plus
13.5. Lobate
13.6. Cosvate G
13.7. Clop G
13.8. Tenovate Gn
13.9. Lobate Gm
13.10. Ultiderm
13.11. Flutivate
13.12. Fexin
13.13. Momate
13.14. Candiderm
13.15. Others

14. Global Topical Corticosteroids Market, By Geography

14.1. Overview

14.2. North America

14.2.1. U.S.
14.2.2. Canada
14.2.3. Mexico

14.3. Europe

14.3.1. Germany
14.3.2. France
14.3.3. U.K.
14.3.4. Italy
14.3.5. Spain
14.3.6. Russia
14.3.7. Turkey
14.3.8. Belgium
14.3.9. Netherlands
14.3.10. Switzerland
14.3.11. Rest Of Europe

14.4. Asia-Pacific

14.4.1. Japan
14.4.2. China
14.4.3. India
14.4.4. South Korea
14.4.5. Australia
14.4.6. Singapore
14.4.7. Thailand
14.4.8. Malaysia
14.4.9. Indonesia
14.4.10. Philippines
14.4.11. Rest Of Asia Pacific

14.5. South America

14.5.1. Brazil
14.5.2. Rest Of South America
14.6. Middle East And Africa
14.6.1. South Africa
14.6.2. Rest Of Middle East And Africa

15. Global Topical Corticosteroids Market, Company Landscape

15.1. Company Share Analysis; Global
15.2. Company Share Analysis; North America
15.3. Company Share Analysis; Europe
15.4. Company Share Analysis; Asia Pacific

16. Company Profiles

16.1. Glaxosmithkline Plc.

16.1.1. Company Overview
16.1.2. Glaxosmithkline Plc; Revenue Analysis
16.1.3. Product Portfolio
16.1.4. Recent Developments

16.2. Merck & Co. Inc.

16.2.1. Company Overview
16.2.2. Merck & Co. Inc.; Revenue Analysis
16.2.3. Product Portfolio
16.2.4. Recent Developments

16.3. Leo Pharma

16.3.1. Company Overview
16.3.2. Leo Pharma; Revenue Analysis
16.3.3. Product Portfolio
16.3.4. Recent Developments

16.4. Almirall S.A.

16.4.1. Company Overview
16.4.2. Almirall S.A.; Company Snapshot
16.4.3. Product Portfolio
16.4.4. Recent Developments

16.5. Valeant Pharmaceuticals International

16.5.1. Company Overview
16.5.2. Valeant Pharmaceuticals International; Revenue Analysis
16.5.3. Product Portfolio
16.5.4. Recent Developments

16.6. Zylera Pharmaceuticals

16.6.1. Company Overview
16.6.2. Zylera Pharmaceuticals; Company Snapshot
16.6.3. Product Portfolio
16.6.4. Recent Developments

16.7. Sandoz International Gmbh

16.7.1. Company Overview
16.7.2. Sandoz International Gmbh; Revenue Analysis
16.7.3. Product Portfolio
16.7.4. Recent Developments

16.8. Pfizer Inc.

16.8.1. Company Overview
16.8.2. Pfizer Inc.; Revenue Analysis
16.8.3. Product Portfolio
16.8.4. Recent Developments

16.9. Sanofi S.A.

16.9.1. Company Overview
16.9.2. Sanofi S.A.; Company Revenue Analysis
16.9.3. Product Portfolio
16.9.4. Recent Developments

16.10. Astrazeneca

16.10.1. Company Overview
16.10.2. Astrazeneca; Revenue Analysis
16.10.3. Product Portfolio
16.10.4. Recent Developments

17. Related Reports